Cardiovascular outcomes and adverse drug reactions associated with the use of ezetimibe in combination with a statin in diabetes mellitus patients with higher risk for myocardial infarction: a meta-analysis
Abstract Background It is well known that diabetes mellitus (DM) is an important risk factor for the development of cardiovascular diseases (CVD). Ezetimibe, an inhibitor of cholesterol absorption, is now a second-line lipid-lowering therapy with apparently more benefits. Ezetimibe can be used in ad...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2026-01-01
|
| سلاسل: | BMC Cardiovascular Disorders |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12872-026-05541-1 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|